T. David et al., CORNEAL WOUND-HEALING MODULATION USING BASIC FIBROBLAST GROWTH-FACTORAFTER EXCIMER-LASER PHOTOREFRACTIVE KERATECTOMY, Cornea, 14(3), 1995, pp. 227-234
Photorefractive keratectomy with the 193-nm excimer laser is one of th
e most promising innovations in refractive surgery. However, routine c
linical application is hindered by two main obstacles, i.e., postopera
tive subepithelial opacity and possible regression of the refractive r
esult. Because we have previously demonstrated beneficial effects of b
asic fibroblast growth factor (bFGF) on corneal epithelial healing in
different in vivo models, we investigated the influence on both epithe
lial and stromal healing of topical bFGF after excimer laser keratomil
eusis in a rabbit model. After 7-mm circular deepithelialization, the
eyes of 24 New Zealand White rabbits received identical deep stromal l
aser ablations (depth 50 mu m, 6 D, diameter 5 mm) and were randomly a
ssigned to one of four treatment groups [control (phosphate-buffered s
aline, PBS), bFGF 10 mu g/application, dexamethasone 0,1%, bFGF + dexa
methasone, n = 12 eyes/group]. All treatments were administered four t
imes daily-bFGF until complete epithelial healing, dexamethasone and P
BS until 3 months postsurgery. Wound surface regression on time was de
termined by means of computer-assisted image analysis of fluorescein-s
tained corneas. Corneal opacity was observed biomicroscopically acid g
raded using a previously established scoring system. After bFGF applic
ation for 2-3 days only, a highly significant acceleration in epitheli
al wound healing speed was found compared with the rate of the other t
hree treatment groups (p < 0.001). A combined therapy (bFGF + steroid)
had no effect on the healing rate, Compared with control values, mean
scores for subepithelial haze in the other groups were found to be ne
arly 50% lower during the first 2 postoperative months. No significant
difference could be seen between eyes that received bFGF, dexamethaso
ne, or bFGF + steroid. These results demonstrate for the first time th
e efficiency of a growth factor in modulating the wound healing respon
se after excimer laser photoablation. Also with regard to possible adv
erse reactions, a short-term and low-dose bFGF application seems advan
tageous over a continuous treatment with corticosteroid drugs.